Clinical effect of Fasudil hydrochloride for cerebral vasospasm following subarachnoid hemorrhage.
Masaoka
H
H
Department of Neurosurgery, National Disaster Medical Center, Tokyo, Japan.
Takasato
Y
Y
Nojiri
T
T
Hayakawa
T
T
Akimoto
H
H
Yatsushige
H
H
Toumori
H
H
Miyazaki
Y
Y
Honma
M
M
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002533:Cerebral Angiography; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy*; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use*; D020301:Vasospasm, Intracranial / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000517:prevention & control*
D014665:Vasodilator Agents; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; C049347:fasudil